Literature DB >> 31573814

A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.

Ryo Ito1, Kenta Umehara2, Shota Suzuki2, Keita Kitamura2, Ken-Ichi Nunoya1, Yoshiyuki Yamaura1, Haruo Imawaka1, Saki Izumi3, Naomi Wakayama3, Takafumi Komori3, Naohiko Anzai4, Hidetaka Akita2, Tomomi Furihata5.   

Abstract

Brain microvascular endothelial cells (BMEC), together with astrocytes and pericytes, form the blood-brain barrier (BBB) that strictly restricts drug penetration into the brain. Therefore, in central nervous system drug development, the establishment of an in vitro human BBB model for use in studies estimating the in vivo human BBB permeability of drug candidates has long been awaited. The current study developed and characterized a human immortalized cell-based BBB triculture model, termed the "hiBBB" model. To set up the hiBBB model, human immortalized BMEC (HBMEC/ci18) were cocultured with human immortalized astrocytes (HASTR/ci35) and brain pericytes (HBPC/ci37) in a transwell system. The trans-endothelial electrical resistance of the hiBBB model was 134.4 ± 5.5 (Ω × cm2), and the efflux ratios of rhodamine123 and dantrolene were 1.72 ± 0.11 and 1.72 ± 0.45, respectively, suggesting that the hiBBB model possesses essential cellular junction and efflux transporter functions. In BBB permeability assays, the mean value of the permeability coefficients (Pe) of BBB permeable compounds (propranolol, pyrilamine, memantine, and diphenhydramine) was 960 × 10-6 cm/s, which was clearly distinguishable from that of BBB nonpermeable compounds (sodium fluorescein and Lucifer yellow, 18 × 10-6 cm/s). Collectively, this study successfully developed the hiBBB model, which exhibits essential BBB functionality. Taking into consideration the high availability of the immortalized cells used in the hiBBB model, our results are expected to become an initial step toward the establishment of a useful human BBB model to investigate drug penetration into the human brain.

Entities:  

Keywords:  blood−brain barrier; central nervous system; drug development; immortalized cells; in vitro BBB model

Mesh:

Substances:

Year:  2019        PMID: 31573814     DOI: 10.1021/acs.molpharmaceut.9b00519

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  Generation of a Human Conditionally Immortalized Cell-based Multicellular Spheroidal Blood-Brain Barrier Model for Permeability Evaluation of Macromolecules.

Authors:  Ryuto Isogai; Hanae Morio; Ayaka Okamoto; Keita Kitamura; Tomomi Furihata
Journal:  Bio Protoc       Date:  2022-08-05

Review 2.  Are In Vitro Human Blood-Brain-Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

Authors:  Archana Prashanth; Heather Donaghy; Shihani P Stoner; Amanda L Hudson; Helen R Wheeler; Connie I Diakos; Viive M Howell; Georges E Grau; Kelly J McKelvey
Journal:  Cancers (Basel)       Date:  2021-02-25       Impact factor: 6.639

Review 3.  Sex differences in the blood-brain barrier and neurodegenerative diseases.

Authors:  Callie M Weber; Alisa Morss Clyne
Journal:  APL Bioeng       Date:  2021-03-16

Review 4.  Review of Design Considerations for Brain-on-a-Chip Models.

Authors:  Tiffany Cameron; Tanya Bennet; Elyn M Rowe; Mehwish Anwer; Cheryl L Wellington; Karen C Cheung
Journal:  Micromachines (Basel)       Date:  2021-04-15       Impact factor: 2.891

5.  Brain microvascular endothelial cells derived from human induced pluripotent stem cells as in vitro model for assessing blood-brain barrier transferrin receptor-mediated transcytosis.

Authors:  Marie Piantino; Fiona Louis; Yukari Shigemoto-Mogami; Kimiko Kitamura; Kaoru Sato; Tomoko Yamaguchi; Kenji Kawabata; Syunsuke Yamamoto; Shinji Iwasaki; Hideki Hirabayashi; Michiya Matsusaki
Journal:  Mater Today Bio       Date:  2022-03-10

6.  Functional analysis of human brain endothelium using a microfluidic device integrating a cell culture insert.

Authors:  Shigenori Miura; Yuya Morimoto; Tomomi Furihata; Shoji Takeuchi
Journal:  APL Bioeng       Date:  2022-03-09

7.  Development of a three-dimensional blood-brain barrier network with opening capillary structures for drug transport screening assays.

Authors:  Marie Piantino; Dong-Hee Kang; Tomomi Furihata; Noriyuki Nakatani; Kimiko Kitamura; Yukari Shigemoto-Mogami; Kaoru Sato; Michiya Matsusaki
Journal:  Mater Today Bio       Date:  2022-06-15

Review 8.  Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood-Brain Barrier.

Authors:  Coraly Simöes Da Gama; Mélanie Morin-Brureau
Journal:  Front Cell Neurosci       Date:  2022-06-10       Impact factor: 6.147

Review 9.  Advancing brain barriers RNA sequencing: guidelines from experimental design to publication.

Authors:  David M F Francisco; Luca Marchetti; Sabela Rodríguez-Lorenzo; Eduardo Frías-Anaya; Ricardo M Figueiredo; Peter Winter; Ignacio Andres Romero; Helga E de Vries; Britta Engelhardt; Rémy Bruggmann
Journal:  Fluids Barriers CNS       Date:  2020-08-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.